India and the Patent Wars: Pharmaceuticals in the New Intellectual Property Regime
India and the Patent Wars contributes to an international debate over the costs of medicine and restrictions on access under stringent patent laws showing how activists and drug companies in low-income countries seize agency and exert influence over these processes. Murphy Halliburton contributes to...
Gespeichert in:
| Beteilige Person: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | Englisch |
| Veröffentlicht: |
Ithaca, NY
Cornell University Press
[2017]
|
| Schriftenreihe: | The Culture and Politics of Health Care Work
|
| Schlagwörter: | |
| Links: | https://www.degruyter.com/doi/book/10.7591/9781501713972 https://www.degruyter.com/doi/book/10.7591/9781501713972 https://www.degruyter.com/doi/book/10.7591/9781501713972 https://www.degruyter.com/doi/book/10.7591/9781501713972 https://www.degruyter.com/doi/book/10.7591/9781501713972 https://www.degruyter.com/doi/book/10.7591/9781501713972 https://www.degruyter.com/doi/book/10.7591/9781501713972 https://www.degruyter.com/doi/book/10.7591/9781501713972 https://www.degruyter.com/doi/book/10.7591/9781501713972 |
| Zusammenfassung: | India and the Patent Wars contributes to an international debate over the costs of medicine and restrictions on access under stringent patent laws showing how activists and drug companies in low-income countries seize agency and exert influence over these processes. Murphy Halliburton contributes to analyses of globalization within the fields of anthropology, sociology, law, and public health by drawing on interviews and ethnographic work with pharmaceutical producers in India and the United States.India has been at the center of emerging controversies around patent rights related to pharmaceutical production and local medical knowledge. Halliburton shows that Big Pharma is not all-powerful, and that local activists and practitioners of ayurveda, India’s largest indigenous medical system, have been able to undermine the aspirations of multinational companies and the WTO. Halliburton traces how key drug prices have gone down, not up, in low-income countries under the new patent regime through partnerships between US- and India-based companies, but warns us to be aware of access to essential medicines in low- and middle-income countries going forward |
| Beschreibung: | Description based on online resource; title from PDF title page (publisher's Web site, viewed 22. Jun 2018) |
| Umfang: | 1 online resource 4 b&w halftones |
| ISBN: | 9781501713972 |
Internformat
MARC
| LEADER | 00000nam a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV045121578 | ||
| 003 | DE-604 | ||
| 005 | 20200423 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 180808s2017 xx |||| o|||| 00||| eng d | ||
| 020 | |a 9781501713972 |9 978-1-5017-1397-2 | ||
| 024 | 7 | |a 10.7591/9781501713972 |2 doi | |
| 024 | 7 | |a 10.7591/9781501713972 |2 doi | |
| 035 | |a (ZDB-23-DGG)9781501713972 | ||
| 035 | |a (OCoLC)1048448389 | ||
| 035 | |a (DE-599)BVBBV045121578 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-859 |a DE-860 |a DE-739 |a DE-473 |a DE-1046 |a DE-29 |a DE-1043 |a DE-858 | ||
| 082 | 0 | |a 346.5404/86 |2 23 | |
| 100 | 1 | |a Halliburton, Murphy |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a India and the Patent Wars |b Pharmaceuticals in the New Intellectual Property Regime |c Murphy Halliburton |
| 264 | 1 | |a Ithaca, NY |b Cornell University Press |c [2017] | |
| 264 | 4 | |c © 2017 | |
| 300 | |a 1 online resource |b 4 b&w halftones | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a The Culture and Politics of Health Care Work | |
| 500 | |a Description based on online resource; title from PDF title page (publisher's Web site, viewed 22. Jun 2018) | ||
| 520 | |a India and the Patent Wars contributes to an international debate over the costs of medicine and restrictions on access under stringent patent laws showing how activists and drug companies in low-income countries seize agency and exert influence over these processes. Murphy Halliburton contributes to analyses of globalization within the fields of anthropology, sociology, law, and public health by drawing on interviews and ethnographic work with pharmaceutical producers in India and the United States.India has been at the center of emerging controversies around patent rights related to pharmaceutical production and local medical knowledge. Halliburton shows that Big Pharma is not all-powerful, and that local activists and practitioners of ayurveda, India’s largest indigenous medical system, have been able to undermine the aspirations of multinational companies and the WTO. Halliburton traces how key drug prices have gone down, not up, in low-income countries under the new patent regime through partnerships between US- and India-based companies, but warns us to be aware of access to essential medicines in low- and middle-income countries going forward | ||
| 546 | |a In English | ||
| 650 | 4 | |a Drugs |z India |x Patents | |
| 650 | 4 | |a Medicine, Ayurvedic |x Economic aspects |z India | |
| 650 | 4 | |a Patent laws and legislation |z India | |
| 650 | 4 | |a Pharmaceutical industry |z India | |
| 650 | 0 | 7 | |a Patentrecht |0 (DE-588)4044884-8 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneimittel |0 (DE-588)4003115-9 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Geistiges Eigentum |0 (DE-588)4136832-0 |2 gnd |9 rswk-swf |
| 651 | 7 | |a Indien |0 (DE-588)4026722-2 |2 gnd |9 rswk-swf | |
| 689 | 0 | 0 | |a Indien |0 (DE-588)4026722-2 |D g |
| 689 | 0 | 1 | |a Arzneimittel |0 (DE-588)4003115-9 |D s |
| 689 | 0 | 2 | |a Patentrecht |0 (DE-588)4044884-8 |D s |
| 689 | 0 | 3 | |a Geistiges Eigentum |0 (DE-588)4136832-0 |D s |
| 689 | 0 | |8 1\p |5 DE-604 | |
| 856 | 4 | 0 | |u https://www.degruyter.com/doi/book/10.7591/9781501713972 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
| 883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 912 | |a ZDB-23-DGG | ||
| 943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-030511710 | |
| 966 | e | |u https://www.degruyter.com/doi/book/10.7591/9781501713972 |l DE-1046 |p ZDB-23-DGG |q FAW_PDA_DGG |x Verlag |3 Volltext | |
| 966 | e | |u https://www.degruyter.com/doi/book/10.7591/9781501713972 |l DE-859 |p ZDB-23-DGG |q FKE_PDA_DGG |x Verlag |3 Volltext | |
| 966 | e | |u https://www.degruyter.com/doi/book/10.7591/9781501713972 |l DE-860 |p ZDB-23-DGG |q FLA_PDA_DGG |x Verlag |3 Volltext | |
| 966 | e | |u https://www.degruyter.com/doi/book/10.7591/9781501713972 |l DE-473 |p ZDB-23-DGG |q UBG_PDA_DGG |x Verlag |3 Volltext | |
| 966 | e | |u https://www.degruyter.com/doi/book/10.7591/9781501713972 |l DE-29 |p ZDB-23-DGG |q UER_PDA_DGG_OA |x Verlag |3 Volltext | |
| 966 | e | |u https://www.degruyter.com/doi/book/10.7591/9781501713972 |l DE-739 |p ZDB-23-DGG |q UPA_PDA_DGG |x Verlag |3 Volltext | |
| 966 | e | |u https://www.degruyter.com/doi/book/10.7591/9781501713972 |l DE-1043 |p ZDB-23-DGG |q FAB_PDA_DGG |x Verlag |3 Volltext | |
| 966 | e | |u https://www.degruyter.com/doi/book/10.7591/9781501713972 |l DE-858 |p ZDB-23-DGG |q FCO_PDA_DGG |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1824415808373129216 |
|---|---|
| adam_text | |
| any_adam_object | |
| author | Halliburton, Murphy |
| author_facet | Halliburton, Murphy |
| author_role | aut |
| author_sort | Halliburton, Murphy |
| author_variant | m h mh |
| building | Verbundindex |
| bvnumber | BV045121578 |
| collection | ZDB-23-DGG |
| ctrlnum | (ZDB-23-DGG)9781501713972 (OCoLC)1048448389 (DE-599)BVBBV045121578 |
| dewey-full | 346.5404/86 |
| dewey-hundreds | 300 - Social sciences |
| dewey-ones | 346 - Private law |
| dewey-raw | 346.5404/86 |
| dewey-search | 346.5404/86 |
| dewey-sort | 3346.5404 286 |
| dewey-tens | 340 - Law |
| discipline | Rechtswissenschaft |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nam a2200000zc 4500</leader><controlfield tag="001">BV045121578</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20200423</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">180808s2017 xx |||| o|||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781501713972</subfield><subfield code="9">978-1-5017-1397-2</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.7591/9781501713972</subfield><subfield code="2">doi</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.7591/9781501713972</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-23-DGG)9781501713972</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1048448389</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV045121578</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-859</subfield><subfield code="a">DE-860</subfield><subfield code="a">DE-739</subfield><subfield code="a">DE-473</subfield><subfield code="a">DE-1046</subfield><subfield code="a">DE-29</subfield><subfield code="a">DE-1043</subfield><subfield code="a">DE-858</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">346.5404/86</subfield><subfield code="2">23</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Halliburton, Murphy</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">India and the Patent Wars</subfield><subfield code="b">Pharmaceuticals in the New Intellectual Property Regime</subfield><subfield code="c">Murphy Halliburton</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Ithaca, NY</subfield><subfield code="b">Cornell University Press</subfield><subfield code="c">[2017]</subfield></datafield><datafield tag="264" ind1=" " ind2="4"><subfield code="c">© 2017</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource</subfield><subfield code="b">4 b&w halftones</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">The Culture and Politics of Health Care Work</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Description based on online resource; title from PDF title page (publisher's Web site, viewed 22. Jun 2018)</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">India and the Patent Wars contributes to an international debate over the costs of medicine and restrictions on access under stringent patent laws showing how activists and drug companies in low-income countries seize agency and exert influence over these processes. Murphy Halliburton contributes to analyses of globalization within the fields of anthropology, sociology, law, and public health by drawing on interviews and ethnographic work with pharmaceutical producers in India and the United States.India has been at the center of emerging controversies around patent rights related to pharmaceutical production and local medical knowledge. Halliburton shows that Big Pharma is not all-powerful, and that local activists and practitioners of ayurveda, India’s largest indigenous medical system, have been able to undermine the aspirations of multinational companies and the WTO. Halliburton traces how key drug prices have gone down, not up, in low-income countries under the new patent regime through partnerships between US- and India-based companies, but warns us to be aware of access to essential medicines in low- and middle-income countries going forward</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">In English</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="z">India</subfield><subfield code="x">Patents</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medicine, Ayurvedic</subfield><subfield code="x">Economic aspects</subfield><subfield code="z">India</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Patent laws and legislation</subfield><subfield code="z">India</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical industry</subfield><subfield code="z">India</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Patentrecht</subfield><subfield code="0">(DE-588)4044884-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Geistiges Eigentum</subfield><subfield code="0">(DE-588)4136832-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="651" ind1=" " ind2="7"><subfield code="a">Indien</subfield><subfield code="0">(DE-588)4026722-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Indien</subfield><subfield code="0">(DE-588)4026722-2</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Patentrecht</subfield><subfield code="0">(DE-588)4044884-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="3"><subfield code="a">Geistiges Eigentum</subfield><subfield code="0">(DE-588)4136832-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="8">1\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://www.degruyter.com/doi/book/10.7591/9781501713972</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-23-DGG</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-030511710</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://www.degruyter.com/doi/book/10.7591/9781501713972</subfield><subfield code="l">DE-1046</subfield><subfield code="p">ZDB-23-DGG</subfield><subfield code="q">FAW_PDA_DGG</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://www.degruyter.com/doi/book/10.7591/9781501713972</subfield><subfield code="l">DE-859</subfield><subfield code="p">ZDB-23-DGG</subfield><subfield code="q">FKE_PDA_DGG</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://www.degruyter.com/doi/book/10.7591/9781501713972</subfield><subfield code="l">DE-860</subfield><subfield code="p">ZDB-23-DGG</subfield><subfield code="q">FLA_PDA_DGG</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://www.degruyter.com/doi/book/10.7591/9781501713972</subfield><subfield code="l">DE-473</subfield><subfield code="p">ZDB-23-DGG</subfield><subfield code="q">UBG_PDA_DGG</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://www.degruyter.com/doi/book/10.7591/9781501713972</subfield><subfield code="l">DE-29</subfield><subfield code="p">ZDB-23-DGG</subfield><subfield code="q">UER_PDA_DGG_OA</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://www.degruyter.com/doi/book/10.7591/9781501713972</subfield><subfield code="l">DE-739</subfield><subfield code="p">ZDB-23-DGG</subfield><subfield code="q">UPA_PDA_DGG</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://www.degruyter.com/doi/book/10.7591/9781501713972</subfield><subfield code="l">DE-1043</subfield><subfield code="p">ZDB-23-DGG</subfield><subfield code="q">FAB_PDA_DGG</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://www.degruyter.com/doi/book/10.7591/9781501713972</subfield><subfield code="l">DE-858</subfield><subfield code="p">ZDB-23-DGG</subfield><subfield code="q">FCO_PDA_DGG</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| geographic | Indien (DE-588)4026722-2 gnd |
| geographic_facet | Indien |
| id | DE-604.BV045121578 |
| illustrated | Not Illustrated |
| indexdate | 2025-02-18T17:08:18Z |
| institution | BVB |
| isbn | 9781501713972 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-030511710 |
| oclc_num | 1048448389 |
| open_access_boolean | |
| owner | DE-859 DE-860 DE-739 DE-473 DE-BY-UBG DE-1046 DE-29 DE-1043 DE-858 |
| owner_facet | DE-859 DE-860 DE-739 DE-473 DE-BY-UBG DE-1046 DE-29 DE-1043 DE-858 |
| physical | 1 online resource 4 b&w halftones |
| psigel | ZDB-23-DGG ZDB-23-DGG FAW_PDA_DGG ZDB-23-DGG FKE_PDA_DGG ZDB-23-DGG FLA_PDA_DGG ZDB-23-DGG UBG_PDA_DGG ZDB-23-DGG UER_PDA_DGG_OA ZDB-23-DGG UPA_PDA_DGG ZDB-23-DGG FAB_PDA_DGG ZDB-23-DGG FCO_PDA_DGG |
| publishDate | 2017 |
| publishDateSearch | 2017 |
| publishDateSort | 2017 |
| publisher | Cornell University Press |
| record_format | marc |
| series2 | The Culture and Politics of Health Care Work |
| spelling | Halliburton, Murphy Verfasser aut India and the Patent Wars Pharmaceuticals in the New Intellectual Property Regime Murphy Halliburton Ithaca, NY Cornell University Press [2017] © 2017 1 online resource 4 b&w halftones txt rdacontent c rdamedia cr rdacarrier The Culture and Politics of Health Care Work Description based on online resource; title from PDF title page (publisher's Web site, viewed 22. Jun 2018) India and the Patent Wars contributes to an international debate over the costs of medicine and restrictions on access under stringent patent laws showing how activists and drug companies in low-income countries seize agency and exert influence over these processes. Murphy Halliburton contributes to analyses of globalization within the fields of anthropology, sociology, law, and public health by drawing on interviews and ethnographic work with pharmaceutical producers in India and the United States.India has been at the center of emerging controversies around patent rights related to pharmaceutical production and local medical knowledge. Halliburton shows that Big Pharma is not all-powerful, and that local activists and practitioners of ayurveda, India’s largest indigenous medical system, have been able to undermine the aspirations of multinational companies and the WTO. Halliburton traces how key drug prices have gone down, not up, in low-income countries under the new patent regime through partnerships between US- and India-based companies, but warns us to be aware of access to essential medicines in low- and middle-income countries going forward In English Drugs India Patents Medicine, Ayurvedic Economic aspects India Patent laws and legislation India Pharmaceutical industry India Patentrecht (DE-588)4044884-8 gnd rswk-swf Arzneimittel (DE-588)4003115-9 gnd rswk-swf Geistiges Eigentum (DE-588)4136832-0 gnd rswk-swf Indien (DE-588)4026722-2 gnd rswk-swf Indien (DE-588)4026722-2 g Arzneimittel (DE-588)4003115-9 s Patentrecht (DE-588)4044884-8 s Geistiges Eigentum (DE-588)4136832-0 s 1\p DE-604 https://www.degruyter.com/doi/book/10.7591/9781501713972 Verlag URL des Erstveröffentlichers Volltext 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
| spellingShingle | Halliburton, Murphy India and the Patent Wars Pharmaceuticals in the New Intellectual Property Regime Drugs India Patents Medicine, Ayurvedic Economic aspects India Patent laws and legislation India Pharmaceutical industry India Patentrecht (DE-588)4044884-8 gnd Arzneimittel (DE-588)4003115-9 gnd Geistiges Eigentum (DE-588)4136832-0 gnd |
| subject_GND | (DE-588)4044884-8 (DE-588)4003115-9 (DE-588)4136832-0 (DE-588)4026722-2 |
| title | India and the Patent Wars Pharmaceuticals in the New Intellectual Property Regime |
| title_auth | India and the Patent Wars Pharmaceuticals in the New Intellectual Property Regime |
| title_exact_search | India and the Patent Wars Pharmaceuticals in the New Intellectual Property Regime |
| title_full | India and the Patent Wars Pharmaceuticals in the New Intellectual Property Regime Murphy Halliburton |
| title_fullStr | India and the Patent Wars Pharmaceuticals in the New Intellectual Property Regime Murphy Halliburton |
| title_full_unstemmed | India and the Patent Wars Pharmaceuticals in the New Intellectual Property Regime Murphy Halliburton |
| title_short | India and the Patent Wars |
| title_sort | india and the patent wars pharmaceuticals in the new intellectual property regime |
| title_sub | Pharmaceuticals in the New Intellectual Property Regime |
| topic | Drugs India Patents Medicine, Ayurvedic Economic aspects India Patent laws and legislation India Pharmaceutical industry India Patentrecht (DE-588)4044884-8 gnd Arzneimittel (DE-588)4003115-9 gnd Geistiges Eigentum (DE-588)4136832-0 gnd |
| topic_facet | Drugs India Patents Medicine, Ayurvedic Economic aspects India Patent laws and legislation India Pharmaceutical industry India Patentrecht Arzneimittel Geistiges Eigentum Indien |
| url | https://www.degruyter.com/doi/book/10.7591/9781501713972 |
| work_keys_str_mv | AT halliburtonmurphy indiaandthepatentwarspharmaceuticalsinthenewintellectualpropertyregime |